Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.020
+0.060 (1.52%)
May 27, 2026, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $285.81 million as of May 27, 2026. Its market cap has increased by 222.95% in one year.
Market Cap
285.81M
Enterprise Value
104.79M
1-Year Change
222.95%
Ranking
Category
Stock Price
$4.02
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $285.81M, a decrease of -51.35%. That is a compound annual growth rate of -11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 281.90M | 222.49% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 306.17M |
| Opus Genetics | 304.17M |
| Eledon Pharmaceuticals | 300.71M |
| Silence Therapeutics | 292.85M |
| Niagen Bioscience | 292.11M |
| Inhibikase Therapeutics | 288.01M |
| MacroGenics | 287.93M |
| AC Immune | 280.74M |